HOME Top Market Reports Allergy Diagnostics Market by Product (Assay Kits, Instruments (Immunoassay Analyzer, Luminometer), Consumables, Services), Allergen (Food, Inhaled, Drug), Tests (In Vivo, In Vitro), End User (Hospital, Diagnostic Laboratory) - Forecast to 2021

Allergy Diagnostics Market by Product (Assay Kits, Instruments (Immunoassay Analyzer, Luminometer), Consumables, Services), Allergen (Food, Inhaled, Drug), Tests (In Vivo, In Vitro), End User (Hospital, Diagnostic Laboratory) - Forecast to 2021

By: marketsandmarkets.com
Publishing Date: June 2016
Report Code: MD 2955

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The global allergy diagnostics market is expected to reach USD 5.34 Billion by 2021 from USD 2.98 Billion in 2016, at a CAGR of 12.4%. The global market is broadly classified by product, test, allergen, end user, and region.

On the basis of products, the allergy diagnostics market is segmented into assay kits, instruments, and services. The assay kits segment is expected to account for the largest share of the global market in 2016. The instruments segment is further categorized into immunoassay analyzers, luminometers, ELISA analyzers, blot analyzers, scanners, clinical chemistry analyzers, mass spectrometers, centrifuges, and molecular diagnostic equipment. These instruments measure the presence of antigenic products in blood or serum samples through the use of antigen-specific antibodies. The immunoassay analyzers segment is expected to account for the largest share of the instruments market, owing to its increasing use in allergy diagnostics.

On the basis of allergen, the allergy diagnostics market is segmented into food allergens, inhaled allergens, drug allergens, and other allergens. The inhaled allergens segment is expected to account for the largest share of the market in 2016, owing to the rising CO2 levels in air and the rising prevalence of allergic diseases such as asthma, COPD, and allergic rhinitis.

On the basis of tests, the allergy diagnostics market is segmented into in vivo tests and in vitro tests. The in vivo tests segment is expected to account for the largest share of the market in 2016, owing to the increasing prevalence of allergic diseases. However, the in vitro tests segment is expected to grow at the highest CAGR in the forecast period.

The end users included in the allergy diagnostics market are diagnostic laboratories, hospitals, academic research institutes, and other end users. The diagnostic laboratories segment is expected to account for the largest share of the global market in 2016. Rise in healthcare spending has resulted in the increasing use of allergy diagnostic products in diagnostic laboratories.

Geographically, the allergy diagnostics market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American region is primarily driven by the increasing population, rising pollution, and increasing prevalence of allergic diseases.

The major players in the allergy diagnostics market are bioMérieux SA (France), Danaher Corporation (U.S.), Hitachi Chemical Diagnostics, Inc. (Japan), Siemens AG (Germany), Thermo Fisher Scientific, Inc. (U.S.), Stallergenes Greer (France), HOB Biotech Group Co., Ltd (China), HYCOR Biomedical (U.S.), Lincoln Diagnostics, Inc. (U.S.), and Omega Diagnostics Group PLC (U.K.).

Target Audience for this Report:

  • Allergy Diagnostics Instrument Manufacturers and Suppliers
  • Academic Research Institutes
  • Diagnostic Laboratories
  • Research and Development (R&D) Companies
  • Business Research And Consulting Service Providers
  • Medical Research Laboratories
  • Academic Medical Centers and Universities

Value Addition for the Buyer:

This report aims to provide insights into the global allergy diagnostics market. It provides valuable information on the product, allergen, test, end user, and regional segments of the market. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to remain competitive in this market.

The above-mentioned information would benefit the buyer by helping them understand the market dynamics. In addition, the forecasts provided in the report will enable firms to understand the trends in this market and better position themselves to capitalize the growth opportunities.

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report:

This report categorizes the allergy diagnostics market into the following segments:

Allergy Diagnostics Market, by Product

  • Assay Kits
  • Instruments
    • Immunoassay Analyzers
    • Luminometers
    • ELISA Analyzers
    • Other Instruments
  • Services

Allergy Diagnostics Market, by Allergen

  • Inhaled Allergens
  • Food Allergens
  • Drug Allergens
  • Other Allergens

Allergy Diagnostics Market, by Test

  • In Vivo Tests
  • In Vitro Tests

Allergy Diagnostics Market, by End User

  • Diagnostic Laboratories
  • Hospitals
  • Academic Research Institutes
  • Others End Users

Allergy Diagnostics Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Spain
    • RoE
  • Asia
    • India
    • China
    • Japan
    • RoA
  • Rest of the World (RoW)
    • South America, Central America, and the Caribbean
    • Pacific and Oceania
    • Africa

Customization Options:

  • Company Information: Detailed company profiles of five or more market players
  • Opportunities Assessment: A detailed report underlining the various growth opportunities presented in the market

Table of Contents

1 Introduction (Page No. - 17)
    1.1 Objectives of the Study
    1.2 Market Definition
           1.2.1 Markets Covered
           1.2.2 Years Considered for the Study
    1.3 Currency
    1.4 Limitations
    1.5 Stakeholders

2 Research Methodology (Page No. - 20)
    2.1 Secondary Data
           2.1.1 Key Data From Secondary Sources
    2.2 Primary Data
           2.2.1 Key Data From Primary Sources
    2.3 Market Size Estimation
           2.3.1 Bottom-Up Approach
           2.3.2 Top-Down Approach
    2.4 Market Breakdown and Data Triangulation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 28)
    3.1 Introduction
    3.2 Current Scenario
    3.3 Future Outlook
    3.4 Conclusion

4 Premium Insights (Page No. - 34)
    4.1 Market Overview
    4.2 Life Cycle Analysis, By Region

5 Market Overview (Page No. - 38)
    5.1 Introduction
    5.2 Market Segmentation
    5.3 Market Dynamics
           5.3.1 Drivers
                    5.3.1.1 High Incidences and Large Economic Burden of Allergic Diseases
                    5.3.1.2 Rising Environmental Pollution
                    5.3.1.3 Increasing Healthcare Expenditure
                    5.3.1.4 Increase in Access to Medical Insurance in the U.S.
           5.3.2 Restraints
                    5.3.2.1 Stringent Regulations for Medical Devices
                    5.3.2.2 Lack of Awareness About Allergic Diseases
                    5.3.2.3 High Capital Requirements
                    5.3.2.4 High Degree of Consolidation Acts as an Entry Barrier for New Entrants
           5.3.3 Opportunities
                    5.3.3.1 Asian Market Presents High-Growth Opportunities
           5.3.4 Trends
                    5.3.4.1 Quick Turnaround Times and High Throughput of Allergy Diagnostic Systems
                    5.3.4.2 Rise in Reagent Rental Agreements

6 Industry Insights (Page No. - 51)
    6.1 Introduction
    6.2 Market Indicators
           6.2.1 High Incidence and Large Economic Burden of Allergic Diseases
    6.3 Industry Trends
           6.3.1 Quick Turnaround Times and High Throughput
    6.4 Porter’s Five Forces Analysis
           6.4.1 Threat From New Entrants
           6.4.2 Threat From Substitutes
           6.4.3 Bargaining Power of Buyers
           6.4.4 Bargaining Power of Suppliers
           6.4.5 Intensity of Rivalry
    6.5 Value Chain Analysis
    6.6 Key Influencers
    6.7 Strategic Benchmarking

7 Allergy Diagnostics Market, By Product (Page No. - 60)
    7.1 Introduction
    7.2 Assay Kits
    7.3 Instruments
           7.3.1 Immunoassay Analyzers
           7.3.2 Luminometers
           7.3.3 Elisa Analyzers
           7.3.4 Other Instruments
    7.4 Services

8 Allergy Diagnostics Market, By Allergens (Page No. - 73)
    8.1 Introduction
    8.2 Inhaled Allergens
    8.3 Food Allergens
    8.4 Drug Allergens
    8.5 Other Allergens

9 Allergy Diagnostics Market, By Test (Page No. - 84)
    9.1 Introduction
    9.2 In Vivo Tests
    9.3 In Vitro Tests

10 Allergy Diagnostics Market, By End User (Page No. - 90)
     10.1 Introduction
     10.2 Diagnostic Laboratories
     10.3 Hospitals
     10.4 Academic Research Institutes
     10.5 Other End Users

11 Allergy Diagnostics Market, By Region (Page No. - 99)
     11.1 Introduction
     11.2 North America
             11.2.1 U.S.
             11.2.2 Canada
     11.3 Europe
             11.3.1 Germany
             11.3.2 U.K.
             11.3.3 France
             11.3.4 Italy
             11.3.5 Spain
             11.3.6 Rest of Europe (RoE)
     11.4 Asia
             11.4.1 China
             11.4.2 Japan
             11.4.3 India
             11.4.4 Rest of Asia (RoA)
     11.5 Rest of the World (RoW)
             11.5.1 South America, Central America & the Caribbean
             11.5.2 Pacific and Oceania
             11.5.3 Africa

12 Competitive Landscape (Page No. - 148)
     12.1 Introduction
     12.2 Strategic Overview
     12.3 Market Share Analysis
     12.4 Competitive Situation and Trends
             12.4.1 New Product Launches
             12.4.2 Expansions
             12.4.3 Agreements, Collaborations, and Partnerships
             12.4.4 Acquisitions
             12.4.5 Other Developments

13 Company Profiles (Page No. - 156)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, Mnm View)*
     13.1 Introduction
     13.2 Biomérieux
     13.3 Danaher Corporation
     13.4 Hitachi Chemical Diagnostics, Inc.
     13.5 Siemens AG
     13.6 Thermo Fisher Scientific, Inc.
     13.7 Hob Biotech Group
     13.8 Hycor Biomedical
     13.9 Lincoln Diagnostics, Inc.
     13.10 Omega Diagnostics Group PLC
     13.11 Stallergenes Greer

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. - 184)
     14.1 Insights of Industry Experts
     14.2 Discussion Guide
     14.3 Other Developments
     14.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
     14.5 Introducing RT: Real-Time Market Intelligence
     14.6 Available Customizations
     14.7 Related Reports


List of Tables (88 Tables)

Table 1 The Economic Burden of Allergies
Table 2 Increasing Healthcare Expenditure is an Important Driver for the Market
Table 3 Stringent Regulatory Policies for Validation of Devices Products to Restrict Market Growth
Table 4 Asia Presents High-Growth Opportunities in the Market
Table 5 High-Throughput Technologies is A Major Trend Observed in the Market
Table 6 Economic Burden of Allergies Boosting the Growth of Market
Table 7 Market Developments Between 2012 and 2016
Table 8 Market Size, By Product, 2014–2021 (USD Million)
Table 9 Allergy Diagnostics Assay Kits Market Size, By Region, 2014–2021 (USD Million)
Table 10 Allergy Diagnostics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 11 Allergy Diagnostics Instruments Market Size, By Region, 2014–2021 (USD Million)
Table 12 Allergy Diagnostics Immunoassay Analyzers Market Size, By Region, 2014–2021 (USD Million)
Table 13 Allergy Diagnostics Luminometers Market Size, By Region, 2014–2021 (USD Million)
Table 14 Allergy Diagnostics Elisa Analyzers Market Size, By Region, 2014–2021 (USD Million)
Table 15 Allergy Diagnostics Other Instruments Market Size, By Region, 2014–2021 (USD Million)
Table 16 Allergy Diagnostics Services Market Size, By Region, 2014–2021 (USD Million)
Table 17 Market Size, By Allergens, 2014–2021 (USD Million)
Table 18 Inhaled Allergen Market Size, By Type, 2014–2021 (USD Million)
Table 19 Market Size for Inhaled Allergens, By Region, 2014–2021 (USD Million)
Table 20 Food Allergen Market Size, By Type, 2014–2021 (USD Million)
Table 21 Market Size for Food Allergens, By Region, 2014–2021 (USD Million)
Table 22 Allergy Diagnosis Market Size for Drug Allergens, By Region, 2014–2021 (USD Million)
Table 23 Allergy Diagnosis Market Size for Other Allergens, By Region, 2014–2021 (USD Million)
Table 24 Market Size, By Test, 2014–2021 (USD Million)
Table 25 In Vivo Allergy Testing Market Size, By Region, 2014–2021 (USD Million)
Table 26 In Vitro Allergy Testing Market Size, By Region, 2014–2021 (USD Million)
Table 27 Market Size, By End User, 2014–2021 (USD Million)
Table 28 Market Size for Diagnostic Laboratories, By Region, 2014–2021 (USD Million)
Table 29 Market Size for Hospitals, By Region, 2014–2021 (USD Million)
Table 30 Market Size for Academic Research Institutes, By Region, 2014–2021 (USD Million)
Table 31 Market Size for Other End Users, By Region, 2014–2021 (USD Million)
Table 32 Market Size, By Region, 2014–2021 (USD Million)
Table 33 North America: Market Size, By Country, 2014–2021 (USD Million)
Table 34 North America: Market Size, By Product, 2014–2021 (USD Million)
Table 35 North America: Market Size, By Test, 2014–2021 (USD Million)
Table 36 North America: Market Size, By Allergen, 2014–2021 (USD Million)
Table 37 North America: Market Size, By End User, 2014–2021 (USD Million)
Table 38 U.S.: Market Size, By Product, 2014–2021 (USD Million)
Table 39 U.S.: Market Size, By End User, 2014–2021 (USD Million)
Table 40 Canada: Market Size, By Product, 2014–2021 (USD Million)
Table 41 Canada: Market Size, By End User, 2014–2021 (USD Million)
Table 42 Europe: Market Size, By Country, 2014–2021 (USD Million)
Table 43 Europe: Market Size, By Product, 2014–2021 (USD Million)
Table 44 Europe: Market Size, By Test, 2014–2021 (USD Million)
Table 45 Europe: Market Size, By Allergen, 2014–2021 (USD Million)
Table 46 Europe: Market Size, By End User, 2014–2021 (USD Million)
Table 47 Germany: Market Size, By Product, 2014–2021 (USD Million)
Table 48 Germany: Market Size, By End User, 2014–2021 (USD Million)
Table 49 U.K.: Market Size, By Product, 2014–2021 (USD Million)
Table 50 U.K.: Market Size, By End User, 2014–2021 (USD Million)
Table 51 France: Market Size, By Product, 2014–2021 (USD Million)
Table 52 France: Market Size, By End User, 2014–2021 (USD Million)
Table 53 Italy: Market Size, By Product, 2014–2021 (USD Million)
Table 54 Italy: Market Size, By End User, 2014–2021 (USD Million)
Table 55 Spain: Market Size, By Product, 2014–2021 (USD Million)
Table 56 Spain: Market Size, By End User, 2014–2021 (USD Million)
Table 57 RoE: Market Size, By Product, 2014–2021 (USD Million)
Table 58 RoE: Market Size, By End User, 2014–2021 (USD Million)
Table 59 Asia: Market Size, By Country, 2014–2021 (USD Million)
Table 60 Asia: Market Size, By Product, 2014–2021 (USD Million)
Table 61 Asia: Market Size, By Test, 2014–2021 (USD Million)
Table 62 Asia: Market Size, By Allergen, 2014–2021 (USD Million)
Table 63 Asia: Market Size, By End User, 2014–2021 (USD Million)
Table 64 China: Market Size, By Product, 2014–2021 (USD Million)
Table 65 China: Market Size, By End User, 2014–2021 (USD Million)
Table 66 Japan: Market Size, By Product, 2014–2021 (USD Million)
Table 67 Japan: Market Size, By End User, 2014–2021 (USD Million)
Table 68 India: Market Size, By Product, 2014–2021 (USD Million)
Table 69 India: Market Size, By End User, 2014–2021 (USD Million)
Table 70 RoA: Market Size, By Product, 2014–2021 (USD Million)
Table 71 RoA: Market Size, By End User, 2014–2021 (USD Million)
Table 72 RoW: Market Size, By Region, 2014–2021 (USD Million)
Table 73 RoW: Market Size, By Product, 2014–2021 (USD Million)
Table 74 RoW: Market Size, By Test, 2014–2021 (USD Million)
Table 75 RoW: Market Size, By Allergen, 2014–2021 (USD Million)
Table 76 RoW: Market Size, By End User, 2014–2021 (USD Million)
Table 77 South America, Central America & the Caribbean: Market Size, By Product, 2014–2021 (USD Million)
Table 78 South America, Central America & the Caribbean: Market Size, By End User, 2014–2021 (USD Million)
Table 79 Pacific and Oceania: Market Size, By Product, 2014–2021 (USD Million)
Table 80 Pacific and Oceania: Market Size, By End User, 2014–2021 (USD Million)
Table 81 Africa: Market Size, By Product, 2014–2021 (USD Million)
Table 82 Africa: Market Size, By End User, 2014–2021 (USD Million)
Table 83 Market Developments Between January 2012 and March 2016
Table 84 New Product Launches, 2012–2016
Table 85 Expansions, 2012–2016
Table 86 Agreements, Collaborations, and Partnerships, 2012–2016
Table 87 Acquisitions, 2012–2016
Table 88 Other Developments, 2012–2016


List of Figures (93 Figures)

Figure 1 Global Allergy Diagnostics Market
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Market: Bottom-Up Approach
Figure 5 Market: Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Market Size, By Product, 2016 vs 2021 (USD Million)
Figure 8 Global Market Size, By Type of Allergen, 2016 vs 2021 (USD Million)
Figure 9 Global Market Size, By Type of Tests, 2016 vs 2021 (USD Million)
Figure 10 Global Allergy Diagnostics Market Size, By End User, 2016 vs 2021 (USD Million)
Figure 11 Global Allergy Diagnostics Market, By Region, 2016 (USD Million)
Figure 12 Global Allergy Diagnostics Market to Witness Moderate Growth During the Forecast Period
Figure 13 Diagnostic Laboratories Segment to Dominate the Allergy Diagnostics Market in 2016
Figure 14 Asia to Wtiness the Fastest Growth in the Forecast Period (2016-2021)
Figure 15 Asian Market Showcases Lucrative Growth Opportunities
Figure 16 Allergy Diagnostics Market Segmentation
Figure 17 High Incidences and Large Economic Burden of Allergic Diseases Will Drive the Allergy Diagnostics Market During the Forecast Period
Figure 18 Rising Environmental Pollution Across the Globe (2010 vs 2011)
Figure 19 Increasing Healthcare Expenditure is A Crucial Factor Driving the Growth of the Allergy Diagnostics Market
Figure 20 Growth in Healthcare Expenditure in Asia and RoW Outpacing That in Americas and Europe
Figure 21 Porter’s Five Forces Analysis (2016): Presence of Large Number of Manufacturing Firms Increases Competition
Figure 22 Major Value is Added During Manufacturing and Assembly Phase
Figure 23 Direct Distribution—Strategy Preferred By Prominent Companies
Figure 24 Allergy Diagnostics Market, By Product
Figure 25 Assay Kits to Form the Largest Product Segment in 2016
Figure 26 North America to Dominate the Allergy Diagnostics Assay Kits Market in 2016
Figure 27 Allergy Diagnostics Instruments Market Size, By Type, 2016 (USD Million)
Figure 28 North America to Command the Largest Share of the Allergy Diagnostics Instruments Market in 2016
Figure 29 North America to Command the Largest Share of the Immunoassay Analyzers Market in 2016
Figure 30 North America to Command the Largest Share of the Luminometers Market in 2016
Figure 31 North America to Command the Largest Share of the Elisa Analyzers Market in 2016
Figure 32 North America to Command the Largest Share of the Other Instruments Market in 2016
Figure 33 North America to Command the Largest Share of the Allergy Diagnostics Services Market in 2016
Figure 34 Allergy Diagnostics Market Segmentation, By Allergens
Figure 35 Inhaled Allergens to Be the Largest Allergen Segment in 2016
Figure 36 Animal Origin to Be the Largest Type Segment in Inhaled Allergen Market in 2016
Figure 37 North America to Command the Largest Share of the Inhaled Allergens Segment in 2016
Figure 38 Plant Origin to Be the Largest Type Segment in Food Allergen Market in 2016
Figure 39 North America to Dominate the Market for Food Allergens in 2016
Figure 40 North America to Command the Largest Share of Drug Allergens Segment in 2016
Figure 41 North America to Dominate the Allergy Diagnosis Market for Other Allergens in 2016
Figure 42 Allergy Diagnostics Market Segmentation, By Test
Figure 43 In Vivo Tests to Form the Largest Test Segment in 2016
Figure 44 North America to Command the Largest Share of the In Vivo Allergy Testing Market in 2016
Figure 45 North America to Command the Largest Share of the In Vitro Allergy Testing Market in 2016
Figure 46 Allergy Diagnostics Market Segmentation, By End User
Figure 47 Allergy Diagnostics Market Size, By End User, 2016 (USD Million)
Figure 48 North America to Dominate the Allergy Diagnostics Market for Diagnostic Laboratories in 2016
Figure 49 North America to Dominate the Allergy Diagnostics Market for Hospitals Between 2016 and 2021
Figure 50 Allergy Diagnostics Market for Academic Research Institutes to Witness Highest Growth in Asia Between 2016 and 2021
Figure 51 North America to Dominate the Allergy Diagnostics Market for Other End Users Between 2016 and 2021
Figure 52 Allergy Diagnostics Market, By Region (Market Size and Growth Rate), 2016-2021
Figure 53 Allergy Diagnostics Market in Asia Expected to Grow at the Highest Rate (2016 to 2021)
Figure 54 North America: Market Snapshot
Figure 55 U.S. to Dominate the North American Allergy Diagnostics Market
Figure 56 Assay Kits Estimated to Be the Largest Product Segment in the North American Allergy Diagnostics Market in 2016
Figure 57 In Vivo Tests Estimated to Be the Largest Segment in the North American Allergy Diagnostics Market in 2016
Figure 58 Inhaled Allergens to Account for the Largest Share of the Market, By Allergen Type, in North America (2016)
Figure 59 Diagnostic Laboratories to Account for the Largest Share of the Market, By End User, in North America
Figure 60 Assay Kits Estimated to Be the Largest Product Segment in the U.S. Allergy Diagnostics Market in 2016
Figure 61 Diagnostic Laboratories to Account for the Largest Share of the End-User Market in the U.S.
Figure 62 Germany is Estimated to Dominate the European Allergy Diagnostics Market in 2016
Figure 63 Assay Kits Estimated to Be the Largest Product Segment in the European Allergy Diagnostics Market in 2016
Figure 64 In Vivo Tests Estimated to Be the Largest Segment in the European Allergy Diagnostics Market in 2016
Figure 65 Inhaled Allergens to Account for the Largest Share of the Allergen in Europe Allergy Diagnostics Market in 2016
Figure 66 Diagnostic Laboratories to Account for the Largest Share of the End-User Market in Europe
Figure 67 Assay Kits Estimated to Be the Largest Product Segment in the German Allergy Diagnostics Market in 2016
Figure 68 Diagnostic Laboratories to Account for the Largest Share of the End-User Market in Germany
Figure 69 Asia: Market Snapshot
Figure 70 China is Estimated to Dominate the Asian Allergy Diagnostics Market in 2016
Figure 71 Assay Kits Estimated to Be the Largest Product Segment in Asian Allergy Diagnostics Market in 2016
Figure 72 In Vivo Tests Estimated to Be the Largest Segment in the Asian Allergy Diagnostics Market in 2016
Figure 73 Inhaled Allergens to Account for the Largest Share of the Allergen in Asian Allergy Diagnostics Market in 2016
Figure 74 Diagnostic Laboratories to Account for the Largest Share of the End-User Market in Asia
Figure 75 Assay Kits Estimated to Be the Largest Product Segment in Chinese Allergy Diagnostics Market in 2016
Figure 76 Diagnostic Laboratories to Account for the Largest Share of the End-User Market in China
Figure 77 South America, Central America, and the Caribbean is Estimated to Dominate the RoW Allergy Diagnostics Market in 2016
Figure 78 Assay Kits Estimated to Be the Largest Product Segment in the RoW Allergy Diagnostics Market in 2016
Figure 79 In Vivo Tests Estimated to Be the Largest Segment in RoW Allergy Diagnostics Market in 2016
Figure 80 Inhaled Allergens to Account for the Largest Share of the Allergen in RoW Allergy Diagnostics Market in 2016
Figure 81 Diagnostic Laboratories to Account for the Largest Share of the End-User Market in RoW
Figure 82 Assay Kits Estimated to Be the Largest Product Segment in South America, Central America, and the Caribbean Allergy Diagnostics Market in 2016
Figure 83 Diagnostic Laboratories to Account for the Largest Share of the End-User Market in South America, Central America & the Caribbean
Figure 84 New Product Launch and Expansions Were the Key Strategies Adopted By Players in the Market
Figure 85 Market Share Analysis, By Key Player, 2015
Figure 86 Financial Performances of the Leading Market Players
Figure 87 Company Snapshot: Biomérieux
Figure 88 Company Snapshot: Danaher Corporation
Figure 89 Company Snapshot: Hitachi Chemical Diagnostics, Inc.
Figure 90 Company Snapshot: Siemens AG
Figure 91 Company Snapshot: Thermo Fisher Scientific, Inc.
Figure 92 Company Snapshot: Omega Diagnostics Group PLC
Figure 93 Company Snapshot: Stallergenes Greer

The global allergy diagnostics market consists of various products that are used by diagnostic laboratories, hospitals, academic institutes, and allergists. The high incidence and large economic burden of allergic diseases has led to the wide application of allergy diagnostics products such as assay kits, instruments, and consumables, thus driving their market growth.
Growth in this market is primarily driven by factors such as increase in the number of allergens and increasing healthcare expenditure worldwide. On the other hand, stringent regulatory policies for validation of medical devices and the highly consolidated market which creates an obstacle for the entry of small players are the major factors restraining the growth of this market.

The allergy diagnostics market is expected to reach USD 5.34 Billion by 2021 from USD 2.98 Billion in 2016, at a CAGR of 12.4% in the forecast period. This market is segmented based on product, allergen, test, end user, and region.

On the basis of product, the allergy diagnostics market is segmented into assay kits, instruments and services. The assay kits segment is expected to account for the largest share of the global market in 2016. Instruments include immunoassay analyzers, luminometers, ELISA analyzers, blot analyzers, scanners, clinical chemistry analyzers, mass spectrometers, centrifuges, and molecular diagnostic equipment. These instruments measure the presence of antigenic products in blood or serum samples through the use of antigen-specific antibodies. Immunoassay analyzers account for largest share of the instruments market owing to its increasing use in allergy diagnostics. However, high cost of instruments hinders its growth.

On the basis of allergen, the allergy diagnostics market is segmented into food allergens, inhaled allergens, drug allergens, and other allergens. The inhaled allergens segment is expected to account for the largest share of the market in 2015, owing to the rising CO2 levels in air and the rising prevalence of allergic diseases such as asthma, COPD, and allergic rhinitis.

On the basis of test, the allergy diagnostics market is segmented into in vivo tests and in vitro tests. The in vivo tests segment is expected to account for the largest share of the market in 2016, owing to the increasing prevalence of allergic diseases. However, the in vitro test segment is expected to grow at the highest CAGR in the forecast period.

Based on end users, the allergy diagnostics market is segmented into diagnostic laboratories, hospitals, academic research institutes, and other end users. The diagnostic laboratories segment is expected to account for the largest share of the global market in 2016. Rise in healthcare spending has resulted in the increasing use of allergy diagnostic products in diagnostic laboratories.

Allergy Diagnostics Market

The global allergy diagnostics market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America will continue to dominate the global market in the forecast period. However, Asia is expected to grow at the highest CAGR, with growth in this market centred at China, Japan, and India.

The major players in this market include bioMérieux SA (France), Danaher Corporation (U.S.), Hitachi Chemical Diagnostics, Inc. (Japan), Siemens AG (Germany), Thermo Fisher Scientific, Inc. (U.S.), Stallergenes Greer (France), HOB Biotech Group Co., Ltd (China), HYCOR Biomedical (U.S.), Lincoln Diagnostics, Inc. (U.S.) and Omega Diagnostics Group PLC (U.K.).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth In-Vitro Diagnostics Markets on KnowledgeStore
Request Demo